medline.ch Psychiatrie Schizophrenie und Psychosen

	Performance and response time in emotion recognition and mentalizing measures in patients with schizophrenia. BMC Psychiatry Ruiz-Toca A, Hernández-Gómez A, Andrade-González N, Fernández-Aragón C, Stiles BJ, Fernandez-Egea E, Rodriguez-Jimenez R, Lahera G. PMID: 42928192 [PubMed - indexed for MEDLINE]
	Moving towards evidence-based screening and investigations in first episode psychosis: A commentary on the ANZJP GRADE Schizophrenia Guidelines. Aust N Z J Psychiatry Chalmers K, Laurie K, Nitz M, Debattista J, Parker S. PMID: 42926310 [PubMed - as supplied by publisher]
	Serum metabolic characteristics and potential biomarkers of first-episode schizophrenia: An exploratory machine learning-based metabolomics study. Prog Neuropsychopharmacol Biol Psychiatry Peng XQ, Liu B, Meng W, Huang J, Zhang Q, Chen L, Li K, Tong HHY, Zhang X, Zhang J, Rao WW. PMID: 42925955 [PubMed - as supplied by publisher]
	Efficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis. Eur Neuropsychopharmacol G, Modrzejewski S, Pola, Wa, Molero P, Wichniak A, Dominiak M, McIntyre RS. PMID: 42925811 [PubMed - as supplied by publisher]
	Can a mobile app improve prognostic accuracy in first episode psychosis? Evidence from ThinkApp using a machine learning approach. J Psychiatr Res Morales-Pillado C, Gutiérrez E, Navas-Loro M, Mayoral M, León-Quismondo L, Ochoa S, Arango C, Rubio-Abadal E, Ibáñez Á, Calvo A. PMID: 42925776 [PubMed - as supplied by publisher]
	Delay in clozapine initiation and subsequent treatment response in schizophrenia spectrum disorders: a systematic review. Psychiatry Res Muñoz-Albero C, Garralda-Puig M, Fonseca F, Guinart D, Martin-Subero M. PMID: 42925631 [PubMed - as supplied by publisher]
	Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit. J Manag Care Spec Pharm Rogers B, Olmsted A, Mo M. PMID: 42925258 [PubMed - indexed for MEDLINE]
	Metabolic biomarker levels before and after initiation of GLP-1 receptor agonist treatment among individuals with schizophrenia: interrupted time-series analysis. Br J Psychiatry Mikkelsen NB, Ørberg A, Østergaard SD, Rohde C. PMID: 42922018 [PubMed - as supplied by publisher]
	Exercise for the negative symptoms of schizophrenia: a review. Front Psychiatry Trevelyan C, Mohsin H. PMID: 42921023 [PubMed]
	Cognitive remediation in schizophrenia: efficacy and role of neuroplasticity in "top-down" and "bottom-up" mechanisms-a randomized, double-blind, treatment-as-usual-controlled study protocol. Front Psychiatry Cifuentes JI, Orellana C, Tello D, Ramírez C, Prieto C, Guasti JM, Nieto RR. PMID: 42920855 [PubMed]
	[Artificial intelligence in the early detection of psychotic disorders: opportunities and limitations of clinical implementation]. Nervenarzt Weyer C, Diederichs N, Meisenzahl E, Koutsouleris N. PMID: 42918865 [PubMed - as supplied by publisher]
	Impact of cannabis use and cannabis composition on formal thought disorder and related brain networks: An fMRI study in 51 patients with schizophrenia. Schizophr Res Bernabeu T, Argote M, Citterio-Quentin A, Giloux N, Sescousse G, Rolland B. PMID: 42914714 [PubMed - as supplied by publisher]
	Disorder of Basic Selfhood in the Schizophrenia Spectrum: A Novel Phenotype. Psychiatr Clin North Am Parnas J, Sandsten KE. PMID: 42914485 [PubMed - indexed for MEDLINE]
	Differentiating predictors of physical and cognitive effort expenditure in early psychosis: A study of reinforcement environment, negative symptoms, and cognitive control. Schizophr Res Tran T, Woolridge SM, Bender K, Tang S, Bowie CR. PMID: 42913280 [PubMed - as supplied by publisher]
	The role of the HPA axis in tailoring cognitive remediation therapy in patients with early psychosis: An exploratory randomized clinical trial. Psychoneuroendocrinology Estrada F, Crosas JM, Ahuir M, Barbero JD, Montalvo I, Tost M, Palao DJ, Monreal JA, Soria V, Nadal R, Armario A, Labad J. PMID: 42913142 [PubMed - as supplied by publisher]
	An Automated Framework Using Magnetic Resonance Imaging Feature Masking and Support Vector Machine for Schizophrenia Classification. J Vis Exp Liu J, Fu C, Liu L. PMID: 42910853 [PubMed - indexed for MEDLINE]
	Metabolic syndrome in stable long-term antipsychotic monotherapy and polypharmacy among patients with schizophrenia: a real-world comparative study. Front Psychiatry Usta H, Be. PMID: 42909145 [PubMed]
	Transcranial ultrasound stimulation of the right globus pallidus interna in schizophrenia: A randomized, sham-controlled pilot study. NPJ Acoust Qi W, Gilad A, Santacatterina M, Brinker S, Capichioni G, Ando F, Shoham S, Goff DC. PMID: 42908713 [PubMed]
	Perceived satisfaction with care, service atmosphere and mood fluctuations among patients with schizophrenia spectrum disorder in Italian mental health supported accommodations: a multicenter study. BMC Psychiatry Martinelli A, Toffol E, Martella D, Carnevale M, Calza S, de Girolamo G. PMID: 42907808 [PubMed - indexed for MEDLINE]
	Treatment- and sham-related improvement and associated factors in non-invasive brain stimulation studies in treatment-resistant schizophrenia: a systematic review and meta-regression analysis. Psychiatry Res Wei Y, Siafis S, Schneider-Thoma J, Kim DD, Vogelmann U, Strube W, Lorenz C, Wu H, Nomura N, Dong S, Furukawa Y, Huber K, Zhu Y, Bighelli I, Li C, Davis JM, Smith RC, Padberg F, Leucht S. PMID: 42906526 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 70127

Seite 1 von 3507



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung